Patents by Inventor Michael L. Bittner

Michael L. Bittner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9255348
    Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.
    Type: Grant
    Filed: August 24, 2007
    Date of Patent: February 9, 2016
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
  • Publication number: 20100144558
    Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.
    Type: Application
    Filed: August 24, 2007
    Publication date: June 10, 2010
    Inventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
  • Patent number: 7003403
    Abstract: Relatedness between genes is quantified by constructing nonlinear models predicting gene expression. Effectiveness of the model is evaluated to provide a measurement of the relatedness of genes associated with the model. Various types of models, including full-logic or neural networks can be constructed. A graphical user interface presents results of the analysis to allow evaluation by a user. Each gene's contribution to the measurement of relatedness can be shown on a graph, and graphical representations of models used to predict gene expression can be displayed.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: February 21, 2006
    Assignees: The United States of America as represented by the Department of Health and Human Services, The Texas A & M University System
    Inventors: Edward R. Dougherty, Seungchan Kim, Michael L. Bittner, Yidong Chen
  • Patent number: 6569626
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: May 27, 2003
    Assignee: Vysis, Inc.
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Publication number: 20020025523
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Application
    Filed: June 21, 2001
    Publication date: February 28, 2002
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Patent number: 6277569
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Grant
    Filed: July 6, 1998
    Date of Patent: August 21, 2001
    Assignee: Vysis, Inc.
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Patent number: 6245517
    Abstract: Gene expression can be quantitatively analyzed by hybridizing fluor-tagged mRNA to targets on a cDNA micro-array. Comparison of gene expression levels arising from co-hybridized samples is achieved by taking ratios of average expression levels for individual genes. In an image-processing phase, a method of image segmentation identifies cDNA target sites in a cDNA micro-array image. The resulting cDNA target sites are analyzed based on a hypothesis test and confidence interval to quantify the significance of observed differences in expression ratios. In particular, the probability density of the ratio and the maximum-likelihood estimator for the distribution are derived, and an iterative procedure for signal calibration is developed.
    Type: Grant
    Filed: September 28, 1999
    Date of Patent: June 12, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Yidong Chen, Edward R. Dougherty, Michael L. Bittner
  • Patent number: 5958754
    Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.
    Type: Grant
    Filed: May 23, 1991
    Date of Patent: September 28, 1999
    Assignee: Monsanto Company
    Inventors: Edith Wong, Michael L. Bittner
  • Patent number: 5789161
    Abstract: Direct label probe compositions which counterstain genomic DNA are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the total genomic DNA of a multi-chromosomal organism, especially man, and the segment mixture is approximately representative of such total genomic DNA. These probe compositions can be used concurrently or sequentially with other probe compositions. Instead of intercalating with DNA as in prior art chemical counterstains, these probe compositions hybridize with complementary segments that are present in the genomic DNA of a specimen.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 4, 1998
    Assignee: AMOCO Corporation
    Inventors: Larry E. Morrison, Mona S. Legator, Michael L. Bittner
  • Patent number: 5776688
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: July 7, 1998
    Assignee: Vysis, Inc.
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Patent number: 5663319
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 2, 1997
    Assignee: Vysis, Inc.
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Patent number: 5652139
    Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: July 29, 1997
    Assignee: Monsanto Company
    Inventors: Edith Wong, Michael L. Bittner
  • Patent number: 5506350
    Abstract: Techniques for producing cloned DNA sequences are provided which sequences are complementary to DNA occurring in one selected region of one chromosome of a multi-chromosomal genome, such as the human genome. Such cloned DNA sequences can be labeled and formed into probes by conventional procedures, there are provided methods for making probe compositions which comprise mixed DNA segments derived from such a DNA sequence. An improved DNA sequence transamination procedure is provided utilizing trifluoroacetate chaotrope anions. With high concentrations of low complexity DNA, high levels of transamination are thereby achieved. These segments are covalently bound to fluorophore groups through linking groups that are transaminated preferably chaotropically into the segments.
    Type: Grant
    Filed: August 19, 1993
    Date of Patent: April 9, 1996
    Inventors: Michael L. Bittner, Lucy M. Stols, Clarissa F. Prorok, Kenneth A. Cruickshank
  • Patent number: 5491224
    Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.
    Type: Grant
    Filed: April 4, 1994
    Date of Patent: February 13, 1996
    Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
  • Patent number: 5489517
    Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamb or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.
    Type: Grant
    Filed: May 23, 1991
    Date of Patent: February 6, 1996
    Assignee: Monsanto Company
    Inventors: Edith Wong, Michael L. Bittner
  • Patent number: 5137817
    Abstract: An electrode set for electrotransformation of a host cell by electroporation, comprising: an electrically insulating substrate; and at least one pair of interdigitated electrodes which are carried by said substrate and which lie in a generally planar array, said electrodes and said substrate being adopted to carry a cell transformant and a host cell thereon, said electrodes and said host cell and said cell transformant being adapted to pass electrical current upon the application of a potential difference across said electrodes.
    Type: Grant
    Filed: October 5, 1990
    Date of Patent: August 11, 1992
    Assignee: Amoco Corporation
    Inventors: Heinz H. Busta, Michael L. Bittner, Richard E. Cuellar
  • Patent number: 5087564
    Abstract: A method for obtaining heterologous peptides from fusion proteins wherein heterologous peptides include eucaryotic hormones such as atrial peptides. A novel DNA sequence encoding atrial peptide III. Various genes, DNA vectors, endopeptidases and transformed bacteria useful in practicing the method of the present invention.
    Type: Grant
    Filed: July 18, 1989
    Date of Patent: February 11, 1992
    Assignee: Monsanto Company
    Inventors: Marilyn S. Mai, Michael L. Bittner, Sarah R. Braford
  • Patent number: 5084384
    Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.
    Type: Grant
    Filed: May 10, 1990
    Date of Patent: January 28, 1992
    Assignee: Monsanto Company
    Inventors: Edith Wong, Michael L. Bittner
  • Patent number: 4843006
    Abstract: This invention relates to the expression and accumulation in bacterial cells of heterologous polypeptides under the control of the recA promoter/operator region. One such polypeptide comprises a recA/somatostatin fusion polypeptide. This fusion polypeptide has been expressed and accumulated by E. coli with much greater effectiveness than other somatostatin-containing fusion polypeptides. In addition, use of the recA promoter/opeerator region provides greater induction flexibility than other inducible promoter systems.
    Type: Grant
    Filed: April 21, 1986
    Date of Patent: June 27, 1989
    Assignee: Monsanto Company
    Inventor: Michael L. Bittner